![James Clark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Clark
Nessuna posizione attualmente
Posizioni attive di James Clark
Società | Posizione | Inizio | Fine |
---|
Storia della carriera di James Clark
Precedenti posizioni note di James Clark
Società | Posizione | Inizio | Fine |
---|---|---|---|
RESPONSE GENETICS, INC | Direttore operativo | 01/10/2006 | 09/02/2009 |
Inivata Ltd.
![]() Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 20/11/2015 | - |
GlaxoSmithKline Biologicals NV
![]() GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Direttore Tecnico/Scientifico/R&S | - | - |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Direttore Tecnico/Scientifico/R&S | - | - |
MDXHEALTH SA | Direttore Tecnico/Scientifico/R&S | 04/11/2010 | - |
Formazione di James Clark
Heriot-Watt University | Undergraduate Degree |
University of Glasgow | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 4 |
Belgio | 3 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
RESPONSE GENETICS, INC | Health Technology |
MDXHEALTH SA | Health Technology |
Aziende private | 3 |
---|---|
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
GlaxoSmithKline Biologicals NV
![]() GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Health Technology |
Inivata Ltd.
![]() Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Borsa valori
- Insiders
- James Clark
- Esperienza